rss
J Neurol Neurosurg Psychiatry 74:944-945 doi:10.1136/jnnp.74.7.944
  • Short report

The role of the PTPRC (CD45) mutation in the development of multiple sclerosis in the North West region of the United Kingdom

Table 1

The incidence of CG mutations at position 77 of exon 4 in PTPRC in the North West region of the United Kingdom

No mutation CD45 exon 4 mutation
MS, multiple sclerosis; PTPRC, protein tyrosine phosphatase receptor, type c polypeptide.
Controls (n (%)) 189 (95.9) 8 (4.1)
MS patients (n (%)) 313 (94.9) 17 (5.1)

This Article

Latest from Practical Neurology

Latest from Practical Neurology

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • BMJ Careers - Latest Neurology and Neurosurgery jobs

    Latest neurology and neurosurgery jobs